Blackstone Inc’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Blackstone Inc’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-78,624	Closed	-$222K	–	203
2024 Q1	$222K	Sell	78,624 -247,928	-76%	-$735K	﹤0.01%	167
2023 Q4	$1.04M	Sell	326,552 -141,593	-30%	-$482K	﹤0.01%	113
2023 Q3	$1.54M	Hold	468,145	–	–	0.01%	116
2023 Q2	$1.54M	Hold	468,145	–	–	0.01%	113
2023 Q1	$1.55M	Hold	468,145	–	–	0.01%	115
2022 Q4	$1.69M	Hold	468,145	–	–	0.01%	97
2022 Q3	$4.14M	Hold	468,145	–	–	0.02%	86
2022 Q2	$3.6M	Hold	468,145	–	–	0.01%	103
2022 Q1	$4.4M	Hold	468,145	–	–	0.01%	134
2021 Q4	$3.24M	Hold	468,145	–	–	0.01%	256
2021 Q3	$4.45M	Hold	468,145	–	–	0.01%	264
2021 Q2	$4.68M	Hold	468,145	–	–	0.01%	259
2021 Q1	$5.48M	Hold	468,145	–	–	0.01%	192
2020 Q4	$16.7M	Hold	468,145	–	–	0.06%	81
2020 Q3	$6.47M	Hold	468,145	–	–	0.03%	114
2020 Q2	$7.72M	Hold	468,145	–	–	0.03%	83
2020 Q1	$3.98M	Buy	+468,145	New	+$6.54M	0.03%	52

Other funds holding LUMO

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

GWM

Greenwich Wealth Management Greenwich, Connecticut $2.75B AUM 36.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Blackstone Inc's LUMO Position: Q2 2024 in Review

Blackstone Inc sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2024, closing a stake of 78,624 shares — an estimated $222K sold.

Blackstone Inc first reported a position in LUMO in Q1 2020 and held it in 17 quarters. The position peaked at $16.7M in Q4 2020. 35 funds tracked by Wall St. Rank hold LUMO as of Q2 2024.

Blackstone Inc reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Blackstone Inc sold 78,624 Lumos Pharma, Inc. Common Stock shares in Q2 2024, an estimated $222K.
Blackstone Inc first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2020 and held it in 17 quarters.
Blackstone Inc's Lumos Pharma, Inc. Common Stock position peaked at $16.7M in Q4 2020.
35 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2024.

Based on Blackstone Inc's 13F filing for Q2 2024, filed 14 Aug 2024.